Cynthia Collins - Jul 23, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Jul 23, 2021
Transactions value $
$0
Form type
4
Date filed
7/26/2021, 08:29 PM
Previous filing
May 28, 2021
Next filing
Aug 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Award $0 +87.4K $0.00 87.4K Jul 23, 2021 Common Stock 87.4K $8.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest and become exercisable in 36 equal monthly installments following the grant date set forth in column 3 above.